Literature DB >> 27899487

Glomerular Endothelial Mitochondrial Dysfunction Is Essential and Characteristic of Diabetic Kidney Disease Susceptibility.

Haiying Qi1, Gabriella Casalena1, Shaolin Shi1, Liping Yu1, Kerstin Ebefors2, Yezhou Sun1, Weijia Zhang1, Vivette D'Agati3, Detlef Schlondorff1, Börje Haraldsson2, Erwin Böttinger1,4, Ilse Daehn5,4.   

Abstract

The molecular signaling mechanisms between glomerular cell types during initiation/progression of diabetic kidney disease (DKD) remain poorly understood. We compared the early transcriptome profile between DKD-resistant C57BL/6J and DKD-susceptible DBA/2J (D2) glomeruli and demonstrated a significant downregulation of essential mitochondrial genes in glomeruli from diabetic D2 mice, but not in C57BL/6J, with comparable hyperglycemia. Diabetic D2 mice manifested increased mitochondrial DNA lesions (8-oxoguanine) exclusively localized to glomerular endothelial cells after 3 weeks of diabetes, and these accumulated over time in addition to increased urine secretion of 8-oxo-deoxyguanosine. Detailed assessment of glomerular capillaries from diabetic D2 mice demonstrated early signs of endothelial injury and loss of fenestrae. Glomerular endothelial mitochondrial dysfunction was associated with increased glomerular endothelin-1 receptor type A (Ednra) expression and increased circulating endothelin-1 (Edn1). Selective Ednra blockade or mitochondrial-targeted reactive oxygen species scavenging prevented mitochondrial oxidative stress of endothelial cells and ameliorated diabetes-induced endothelial injury, podocyte loss, albuminuria, and glomerulosclerosis. In human DKD, increased urine 8-oxo-deoxyguanosine was associated with rapid DKD progression, and biopsies from patients with DKD showed increased mitochondrial DNA damage associated with glomerular endothelial EDNRA expression. Our studies show that DKD susceptibility was linked to mitochondrial dysfunction, mediated largely by Edn1-Ednra in glomerular endothelial cells representing an early event in DKD progression, and suggest that cross talk between glomerular endothelial injury and podocytes leads to defects and depletion, albuminuria, and glomerulosclerosis.
© 2017 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27899487      PMCID: PMC5319717          DOI: 10.2337/db16-0695

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  58 in total

Review 1.  The glomerular endothelium: new insights on function and structure.

Authors:  Börje Haraldsson; Jenny Nyström
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-05       Impact factor: 2.894

2.  Elevated plasma endothelin in patients with diabetes mellitus.

Authors:  K Takahashi; M A Ghatei; H C Lam; D J O'Halloran; S R Bloom
Journal:  Diabetologia       Date:  1990-05       Impact factor: 10.122

3.  Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy.

Authors:  Eva Lonn; Salim Yusuf; Byrcon Hoogwerf; Janice Pogue; Qilong Yi; Bernard Zinman; Jackie Bosch; Gilles Dagenais; Johannes F E Mann; Hertzel C Gerstein
Journal:  Diabetes Care       Date:  2002-11       Impact factor: 19.112

4.  Hyaluronidase 1 Deficiency Preserves Endothelial Function and Glycocalyx Integrity in Early Streptozotocin-Induced Diabetes.

Authors:  Sophie Dogné; Géraldine Rath; François Jouret; Nathalie Caron; Chantal Dessy; Bruno Flamion
Journal:  Diabetes       Date:  2016-05-31       Impact factor: 9.461

Review 5.  The glomerulus--a view from the inside--the endothelial cell.

Authors:  Agnes B Fogo; Valentina Kon
Journal:  Int J Biochem Cell Biol       Date:  2010-06-09       Impact factor: 5.085

6.  Irbesartan treatment reduces biomarkers of inflammatory activity in patients with type 2 diabetes and microalbuminuria: an IRMA 2 substudy.

Authors:  Frederik Persson; Peter Rossing; Peter Hovind; Coen D A Stehouwer; Casper Schalkwijk; Lise Tarnow; Hans-Henrik Parving
Journal:  Diabetes       Date:  2006-12       Impact factor: 9.461

7.  Clinical efficacy of the selective endothelin A receptor antagonist, atrasentan, in patients with diabetes and chronic kidney disease (CKD).

Authors:  Dennis L Andress; Blai Coll; Yili Pritchett; John Brennan; Mark Molitch; Donald E Kohan
Journal:  Life Sci       Date:  2012-02-02       Impact factor: 5.037

8.  Mitochondrial reserve capacity in endothelial cells: The impact of nitric oxide and reactive oxygen species.

Authors:  Brian P Dranka; Bradford G Hill; Victor M Darley-Usmar
Journal:  Free Radic Biol Med       Date:  2010-01-20       Impact factor: 7.376

9.  The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin.

Authors:  Alexander V Birk; Shaoyi Liu; Yi Soong; William Mills; Pradeep Singh; J David Warren; Surya V Seshan; Joel D Pardee; Hazel H Szeto
Journal:  J Am Soc Nephrol       Date:  2013-07-11       Impact factor: 10.121

10.  Mitochondrial reactive oxygen species in the pathogenesis of early diabetic nephropathy.

Authors:  Takeshi Nishikawa; Michael Brownlee; Eiichi Araki
Journal:  J Diabetes Investig       Date:  2014-07-25       Impact factor: 4.232

View more
  68 in total

1.  FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity.

Authors:  Xiaoxin X Wang; Dong Wang; Yuhuan Luo; Komuraiah Myakala; Evgenia Dobrinskikh; Avi Z Rosenberg; Jonathan Levi; Jeffrey B Kopp; Amanda Field; Ashley Hill; Scott Lucia; Liru Qiu; Tao Jiang; Yingqiong Peng; David Orlicky; Gabriel Garcia; Michal Herman-Edelstein; Vivette D'Agati; Kammi Henriksen; Luciano Adorini; Mark Pruzanski; Cen Xie; Kristopher W Krausz; Frank J Gonzalez; Suman Ranjit; Alexander Dvornikov; Enrico Gratton; Moshe Levi
Journal:  J Am Soc Nephrol       Date:  2017-10-31       Impact factor: 10.121

2.  Endothelin receptor-A mediates degradation of the glomerular endothelial surface layer via pathologic crosstalk between activated podocytes and glomerular endothelial cells.

Authors:  Kerstin Ebefors; Robert J Wiener; Liping Yu; Evren U Azeloglu; Zhengzi Yi; Fu Jia; Weijia Zhang; Margaret H Baron; John C He; Börje Haraldsson; Ilse Daehn
Journal:  Kidney Int       Date:  2019-05-22       Impact factor: 10.612

3.  Combined use of electron microscopy and intravital imaging captures morphological and functional features of podocyte detachment.

Authors:  James L Burford; Georgina Gyarmati; Isao Shirato; Wilhelm Kriz; Kevin V Lemley; János Peti-Peterdi
Journal:  Pflugers Arch       Date:  2017-06-29       Impact factor: 3.657

Review 4.  Sex differences in renal mitochondrial function: a hormone-gous opportunity for research.

Authors:  Regina F Sultanova; Ryan Schibalski; Irina A Yankelevich; Krisztian Stadler; Daria V Ilatovskaya
Journal:  Am J Physiol Renal Physiol       Date:  2020-11-02

5.  Plasma concentrations of 8-hydroxy-2'-deoxyguanosine and risk of kidney disease and death in individuals with type 1 diabetes.

Authors:  Manuel Sanchez; Ronan Roussel; Samy Hadjadj; Abdul Moutairou; Michel Marre; Gilberto Velho; Kamel Mohammedi
Journal:  Diabetologia       Date:  2017-11-28       Impact factor: 10.122

6.  Podocyte and endothelial-specific elimination of BAMBI identifies differential transforming growth factor-β pathways contributing to diabetic glomerulopathy.

Authors:  Han Lai; Anqun Chen; Hong Cai; Jia Fu; Fadi Salem; Yu Li; John C He; Detlef Schlondorff; Kyung Lee
Journal:  Kidney Int       Date:  2020-04-26       Impact factor: 10.612

Review 7.  Mitochondrial dysfunction in diabetic kidney disease.

Authors:  Josephine M Forbes; David R Thorburn
Journal:  Nat Rev Nephrol       Date:  2018-02-19       Impact factor: 28.314

Review 8.  The Warburg Effect in Diabetic Kidney Disease.

Authors:  Guanshi Zhang; Manjula Darshi; Kumar Sharma
Journal:  Semin Nephrol       Date:  2018-03       Impact factor: 5.299

Review 9.  Mitochondrial quality control in kidney injury and repair.

Authors:  Chengyuan Tang; Juan Cai; Xiao-Ming Yin; Joel M Weinberg; Manjeri A Venkatachalam; Zheng Dong
Journal:  Nat Rev Nephrol       Date:  2020-11-24       Impact factor: 28.314

10.  Mitochondria-related reversal of early-stage diabetic nephropathy in donor kidney after transplantation in mice.

Authors:  Weinan Wu; Yiming Jin; Lisha Teng; Xue Shao; Yucheng Wang; Shi Feng; Cuili Wang; Hong Jiang; Jianyong Wu
Journal:  Ann Transl Med       Date:  2019-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.